EGFR and lung adenocarcinoma: We investigated the relationship between miR-122 and EGFR mutation status along with survival in non-smoking female lung adenocarcinoma, and found that reduced expression of miR-122 in plasma was associated with EGFR mutation and favorable survival, especially in patients with advanced disease.